Literature DB >> 11114722

The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism.

J Cizeau1, R Ray, G Chen, R D Gietz, A H Greenberg.   

Abstract

We have studied ceBNIP3, the orthologue of BNIP3 in C. elegans. Sequence analysis reveals that the different domains of BNIP3 have been conserved throughout evolution. ceBNIP3 contains a C-terminal transmembrane (TM) domain, a conserved domain (CD) of 19 amino acids, a BCL-2 homology-3 (BH3)-like domain and a PEST sequence. ceBNIP3 is expressed primarily as a 25 kDa monomer and a 50 kDa homodimer. After transfection, ceBNIP3 protein is rapidly degraded through a ubiquitin-dependent pathway by the proteasome. Like BNIP3, the TM domain of ceBNIP3 mediates the localization of the protein to mitochondria and is also necessary for homodimerization and cell death in mammalian cells. Neither the putative BH3 domain nor conserved domain is necessary for killing. ceBNIP3 protein interacts with CED-9 and BCL-XL, but unlike other pro-apoptotic BCL-2 family members, the BH3-like domain does not participate in dimerization. The ceBNIP3 TM domain mediates interaction with both CED-9 and BCL-XL. ceBNIP3 interacts with CED-3 but co-expression of CED-3 and ceBNIP3 does not significantly enhance induction of cell death in the presence or absence of CED-4. ceBNIP3 kills mammalian cells by a caspase-independent mechanism. In conclusion, we find that although ceBNIP3 interacts with CED-9 and CED-3 it kills by a BH3- and caspase-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114722     DOI: 10.1038/sj.onc.1203929

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  The C. elegans B-cell lymphoma 2 (Bcl-2) homolog cell death abnormal 9 (CED-9) associates with and remodels LIPID membranes.

Authors:  Frederick J Tan; Jonathan E Zuckerman; Robert C Wells; R Blake Hill
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

Review 2.  The role of Bcl-2 family member BNIP3 in cell death and disease: NIPping at the heels of cell death.

Authors:  T R Burton; S B Gibson
Journal:  Cell Death Differ       Date:  2009-01-09       Impact factor: 15.828

Review 3.  Cell Death in C. elegans Development.

Authors:  Jennifer Zuckerman Malin; Shai Shaham
Journal:  Curr Top Dev Biol       Date:  2015-09-09       Impact factor: 4.897

4.  Truncated forms of BNIP3 act as dominant negatives inhibiting hypoxia-induced cell death.

Authors:  Nicolle Bristow; Teralee R Burton; Elizabeth S Henson; Coleen Ong-Justiniano; Michelle Brown; Spencer B Gibson
Journal:  Biochim Biophys Acta       Date:  2010-12-05

Review 5.  The rationale for cardiomyocyte resuscitation in myocardial salvage.

Authors:  Gerald W Dorn; Abhinav Diwan
Journal:  J Mol Med (Berl)       Date:  2008-06-19       Impact factor: 4.599

6.  A short linear motif in BNIP3L (NIX) mediates mitochondrial clearance in reticulocytes.

Authors:  Ji Zhang; Melanie R Loyd; Mindy S Randall; M Brett Waddell; Richard W Kriwacki; Paul A Ney
Journal:  Autophagy       Date:  2012-08-21       Impact factor: 16.016

7.  A nucleus-targeted alternately spliced Nix/Bnip3L protein isoform modifies nuclear factor κB (NFκB)-mediated cardiac transcription.

Authors:  Yun Chen; Keith F Decker; Dali Zheng; Scot J Matkovich; Li Jia; Gerald W Dorn
Journal:  J Biol Chem       Date:  2013-04-19       Impact factor: 5.157

Review 8.  Role of BNIP3 and NIX in cell death, autophagy, and mitophagy.

Authors:  J Zhang; P A Ney
Journal:  Cell Death Differ       Date:  2009-02-20       Impact factor: 15.828

9.  Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation.

Authors:  Abhinav Diwan; Janaka Wansapura; Faisal M Syed; Scot J Matkovich; John N Lorenz; Gerald W Dorn
Journal:  Circulation       Date:  2008-01-04       Impact factor: 29.690

Review 10.  BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions.

Authors:  G Chinnadurai; S Vijayalingam; S B Gibson
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.